Patent · US Active

Enone reductases

US10035988B2 · kind B2 · utility

2Cited by
13References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2017
Grant dateJul 31, 2018
Priority date
Expiry dateFeb 27, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure relates to engineered enone reductase polypeptides having improved properties, polynucleotides encoding the engineered polypeptides, related vectors, host cells, and methods for making the engineered enone reductase polypeptides. The disclosure also provides methods of using the engineered enone reductase polypeptides for chemical transformations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.